AI biotech Fathom raises $47M Series A, renames from Atommap

From L-R: Fathom Therapeutics founder and CEO Huafeng Xu, with co-founders Yujie Wu and Jesus Izaguirre April 27, 2026 07:00 AM EDT FinancingAI Ex­clu­sive: Fath­om rais­es $47M, blend­ing AI and physics in drug dis­cov­ery Andrew Dunn Senior Biopharma Correspondent In the ear­ly 2000s, way be­fore AI be­came a ubiq­ui­tous buzz­word in biotech, bil­lion­aire sci­en­tist David Shaw was build­ing su­per­com­put­ers to study mol­e­cules at his … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER